Armata Pharmaceuticals, Inc. SC 13D and SC 13D/A reports

Location
5005 Mcconnell Ave, Los Angeles, CA
State of incorporation
WA
Fiscal year end
December 31
Data updated at
8/30/2024, 01:36 AM
Form type Sec Links Description Filing date Reporting date
SC 13D/A Report SC 13D/A Mar 4, 2024
SC 13D/A Report SC 13D/A Jul 11, 2023
SC 13D/A Report SC 13D/A Jan 10, 2023
SC 13D/A Report SCHEDULE 13D/A, AMENDMENT #7 Apr 1, 2022
SC 13D/A Report SCHEDULE 13D/A (AMENDMENT NO. 6) Feb 11, 2022
SC 13D/A Report SCHEDULE 13D/A (AMENDMENT NO. 5) Nov 1, 2021
SC 13D/A Report SCHEDULE 13D (AMENDMENT NO. 4) Apr 5, 2021
SC 13D/A Report SCHEDULE 13D/A, AMENDMENT #3 Mar 17, 2021
SC 13D/A Report SCHEDULE 13D/A, AMENDMENT #2 Jan 27, 2021
SC 13D/A Report SCHEDULE 13D/A, #1 Mar 31, 2020
SC 13D Report SCHEDULE 13D Feb 14, 2020
SC 13D Report SC 13D May 21, 2019
SC 13D/A Report RANDAL J KIRK SC 13D/A NO 3 12-30-2016 (AMPLIPHI BIOSCIENCES CORP) Dec 30, 2016
SC 13D/A Report RANDAL J KIRK SC 13D A NO 2 11-12-2016 (AMPLIPHI BIOSCIENCES CORP) Nov 16, 2016
SC 13D/A Report | Data RANDAL J. KIRK SC 13D A NO. 1 4-15-2016 (AMPLIPHI BIOSCIENCES CORPORATION) Apr 15, 2016
SC 13D Report RANDAL J KIRK SC 13D 3-16-2015 (AMPLIPHI BIOSCIENCES CORP) Mar 20, 2015
SC 13D Report Aug 4, 2010